This site is intended for healthcare professionals only
LoginRegister
Himachal to develop medical device park independentlyMedical device manufacturers need to resubmit MSC and NCC as CDSCO launches Automated Process
AstraZeneca eyes year-end filing for BP drug BaxdrostatAstraZeneca Gets CDSCO Panel Nod To study Tezepelumab
Wockhardt seeks DCGI nod for ZaynichUS tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman
BioArctic inks pact with Novartis regarding treatment combining BrainTransporter technology with undisclosed target in neurodegenerationNovartis plans to invest USD 23 billion over next 5 years in US based infrastructure
CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten StudyPomalyst monopoly case: Bristol Myers wins dismissal of lawsuit
Pharmacy Practice RegulationsD.Pharm To Remain Minimum Qualification To Become Pharmacist in Bihar: Patna HC
Morepen Labs plans to employ over 1000 professionalsMorepen Labs plans to employ over 1000 professionals
Raid at quack clinic in Telangana, drugs including Amoxycillin seizedRaid at quack clinic in Telangana, drugs including Amoxycillin seized
Regulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult DataZydus Lifesciences bags USFDA nod for Duchenne muscular dystrophy drug Jaythari
JnJ seeks USFDA approval for Tremfya label updateJohnson & Johnson gets CDSCO Panel for additional indication of Amivantamab Liquid Concentrate for...
Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic DermatitisSubmit Phase III CT data with Pk and Pd data: CDSCO Panel Tells Intas Pharmaceuticals on Human von...
Aurobindo Pharma arm Telangana facility gets 5 USFDA observationsAurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant
X